ArticleESMO gastrointestinal oncology2026
Preclinical identification and clinical validation of dynamic biomarkers for trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer.
M Suenaga et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.